Remove 2018 Remove Epilepsy Remove Treatment
article thumbnail

How does medical marijuana help patients with Epilepsy?

FloridaMarijuana.net

The Epilepsy Foundation defines epilepsy as a chronic condition of the brain which causes seizures and affects 65 million people worldwide. One in 26 people will develop epilepsy in their lifetime. It is not fully known the genetic origins of epilepsy or if the condition is hereditary. appeared first on.

Epilepsy 187
article thumbnail

The Science Behind Medical Marijuana: Exploring Cannabinoids and Their Therapeutic Effects

MMJ Recs

Epilepsy Management: CBD, in particular, has emerged as an effective treatment for epilepsy, especially in individuals with rare and severe forms of the condition. Neurological Disorders: Several cannabinoids show promise in the treatment of neurological disorders, including multiple sclerosis (MS) and Parkinson’s disease.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Epidiolex CBD Epilepsy Drug Receives Approval in Europe

WeedAdvisor

On June 25, 2018, the U.S. GW Pharmaceuticals created the medication after studies showed surprising success treating severe childhood epilepsy, specifically Lennox-Gastaut Syndrome and Dravet Syndrome. The post Epidiolex CBD Epilepsy Drug Receives Approval in Europe appeared first on WeedAdvisor. In the U.S.,

article thumbnail

Tory back bench block Manchester MP’s bid to give patients access to NHS cannabis treatments

Cannabis Law Report

A Manchester MP’s bid to open up cannabis treatments on the NHS has been blocked by Tory backbenchers in the House of Commons. 'A Despite the Government legalising medicinal cannabis in 2018, following a number of high-profile campaigns, thousands of people are still being denied access to the treatment.

article thumbnail

CBD may help improve seizures, cognition

Medical Marijuana Program Connection

Share on PinterestCBD may not only help to reduce seizure-related symptoms in people with epilepsy, research shows. Rowena Naylor/Stocksy United Cannabidiol (CBD) has been approved for use in the treatment of two early-onset, intractable forms of epilepsy, Dravet syndrome and Lennox-Gastaut syndrome, since 2018.

article thumbnail

Study Finds Healthcare Providers Need More Education On Cannabis

MedicalJane

A newly published article in the Epilepsy & Behavior Journal highlights the findings of researchers at the University of Alabama at Birmingham after surveying healthcare providers on their attitudes and knowledge about cannabis, and has confirmed what most of us already knew– healthcare providers need more education on cannabis.

Education 122
article thumbnail

Answer of the Day for Jul 18, 2022

TheAnswerPage

In 2017, researchers performed an analysis of observational clinical studies on the treatment of refractory epilepsy with cannabidiol (CBD)-based products. Their findings included the following: “The average daily dose ranged between 1 and 50 mg/kg, with treatment length from 3 to 12 months (mean 6.2 12 September 2018.